Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002312765 | SCV000847188 | uncertain significance | Inborn genetic diseases | 2016-07-13 | criteria provided, single submitter | clinical testing | The c.200_205dupGCCGCG variant (also known as p.G67_R68dup), located in coding exon 1 of the CTSF gene, results from an in-frame duplication of GCCGCG at nucleotide positions 200 to 205. This results in the duplication of 2 extra residues (GR) between codons 67 and 68. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 2415 samples (4830 alleles) with coverage at this position. These amino acid positions are well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001434056 | SCV001636857 | likely benign | Neuronal ceroid lipofuscinosis 13 | 2024-03-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001731905 | SCV001982581 | uncertain significance | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing | In-frame duplication of 2 amino acids in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) |
Mayo Clinic Laboratories, |
RCV001731905 | SCV004226190 | uncertain significance | not provided | 2023-02-24 | criteria provided, single submitter | clinical testing | PM4 |